Advanced search
Add to list

An international multi-centre, randomized, open-label, phase III trial comparing rituximab added to CVP chemotherapy to CVP chemotherapy alone in untreated stage III/IV follicular non-Hodgkins lymphoma

(2003) BLOOD. 102(11).
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
MARCUS, R, K IMRIE, A BELCH, et al. “An International Multi-centre, Randomized, Open-label, Phase III Trial Comparing Rituximab Added to CVP Chemotherapy to CVP Chemotherapy Alone in Untreated Stage III/IV Follicular non-Hodgkins Lymphoma.” Blood. Vol. 102. AMER SOC HEMATOLOGY, 2003. 28. Print.
APA
MARCUS, R., IMRIE, K., BELCH, A., CUNNINGHAM, D., FLORES, E., CATALANO, J., SOLAL-CELIGNY, P., et al. (2003). An international multi-centre, randomized, open-label, phase III trial comparing rituximab added to CVP chemotherapy to CVP chemotherapy alone in untreated stage III/IV follicular non-Hodgkins lymphoma. BLOOD (Vol. 102, p. 28). AMER SOC HEMATOLOGY.
Chicago author-date
MARCUS, R, K IMRIE, A BELCH, D CUNNINGHAM, E FLORES, J CATALANO, P SOLAL-CELIGNY, et al. 2003. “An International Multi-centre, Randomized, Open-label, Phase III Trial Comparing Rituximab Added to CVP Chemotherapy to CVP Chemotherapy Alone in Untreated Stage III/IV Follicular non-Hodgkins Lymphoma.” In Blood, 102:28. AMER SOC HEMATOLOGY.
Chicago author-date (all authors)
MARCUS, R, K IMRIE, A BELCH, D CUNNINGHAM, E FLORES, J CATALANO, P SOLAL-CELIGNY, Fritz Offner, J WALEWSKI, J RAPOSO, A JACK, and P SMITH. 2003. “An International Multi-centre, Randomized, Open-label, Phase III Trial Comparing Rituximab Added to CVP Chemotherapy to CVP Chemotherapy Alone in Untreated Stage III/IV Follicular non-Hodgkins Lymphoma.” In Blood, 102:28. AMER SOC HEMATOLOGY.
Vancouver
1.
MARCUS R, IMRIE K, BELCH A, CUNNINGHAM D, FLORES E, CATALANO J, et al. An international multi-centre, randomized, open-label, phase III trial comparing rituximab added to CVP chemotherapy to CVP chemotherapy alone in untreated stage III/IV follicular non-Hodgkins lymphoma. BLOOD. AMER SOC HEMATOLOGY; 2003. p. 28.
IEEE
[1]
R. MARCUS et al., “An international multi-centre, randomized, open-label, phase III trial comparing rituximab added to CVP chemotherapy to CVP chemotherapy alone in untreated stage III/IV follicular non-Hodgkins lymphoma,” in BLOOD, 2003, vol. 102, no. 11, p. 28.
@inproceedings{308213,
  author       = {MARCUS, R and IMRIE, K and BELCH, A and CUNNINGHAM, D and FLORES, E and CATALANO, J and SOLAL-CELIGNY, P and Offner, Fritz and WALEWSKI, J and RAPOSO, J and JACK, A and SMITH, P},
  booktitle    = {BLOOD},
  issn         = {0006-4971},
  language     = {eng},
  number       = {11},
  pages        = {28A-28A},
  publisher    = {AMER SOC HEMATOLOGY},
  title        = {An international multi-centre, randomized, open-label, phase III trial comparing rituximab added to CVP chemotherapy to CVP chemotherapy alone in untreated stage III/IV follicular non-Hodgkins lymphoma},
  volume       = {102},
  year         = {2003},
}

Web of Science
Times cited: